A Dose Block-randomized, Double-blind, Placebo- and Active-controlled, Single and Multiple Dosing, Dose-escalation Clinical Phase 1 Trial to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Male Volunteers

Trial Profile

A Dose Block-randomized, Double-blind, Placebo- and Active-controlled, Single and Multiple Dosing, Dose-escalation Clinical Phase 1 Trial to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Male Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Apr 2017

At a glance

  • Drugs DWP 14012 (Primary) ; Esomeprazole
  • Indications Peptic ulcer
  • Focus Adverse reactions
  • Sponsors Daewoong Pharmaceutical
  • Most Recent Events

    • 23 Apr 2017 Status changed from recruiting to completed.
    • 01 Nov 2016 Planned number of patients changed from 108 to 120.
    • 01 Nov 2016 Planned primary completion date changed from 1 Oct 2016 to 1 Feb 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top